$37.9 million for a wearable that must prove its clinical role
MIT’s four-year PYTHIA programme targets continuous biomarker measurement. Its development plan runs from sensors and power supply to validation and clinical testing.
Where human wellbeing meets the possibilities of science and technology.
MIT’s four-year PYTHIA programme targets continuous biomarker measurement. Its development plan runs from sensors and power supply to validation and clinical testing.